Showing results (971-980 of 987) with videos related to

Sort By:
Pageof 99
Cancer Discovery|June 9, 2018
<i>MACROD2</i> Haploinsufficiency Impairs Catalytic Activity of PARP1 and Promotes Chromosome Instability and Growth of Intestinal TumorsAnuratha Sakthianandeswaren, Marie J Parsons, Dmitri Mouradov, et al.
Oncogene|October 23, 2012
Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesisM Christie, R N Jorissen, D Mouradov, et al.
The Journal of Pathology|February 20, 2026
Deep learning-based H&E-derived risk scores in colorectal cancer: associations with tumour morphology, biology, and predicted drug responseNic G Reitsam, Xiaofeng Jiang, Junhao Liang, et al.
Oncotarget|May 12, 2016
Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancerNirosha Suraweera, Dmitri Mouradov, Shan Li, et al.
Marine Pollution Bulletin|June 13, 2025
Hindsight informs foresight: revisiting millennial forecasts of impacts and status of rocky shores in 2025Stephen J Hawkins, Kathryn A O'Shaughnessy, George M Branch, et al.
Cancer Research|November 10, 2012
SMAD2, SMAD3 and SMAD4 mutations in colorectal cancerNicholas I Fleming, Robert N Jorissen, Dmitri Mouradov, et al.
Diabetes|November 4, 2022
Multi-Scalar Data Integration Links Glomerular Angiopoietin-Tie Signaling Pathway Activation With Progression of Diabetic Kidney DiseaseJiahao Liu, Viji Nair, Yi-Yang Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2013
PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancerFiona L Day, Robert N Jorissen, Lara Lipton, et al.
International Journal of Molecular Sciences|August 10, 2024
<i>Para</i>-Hydroxycinnamic Acid Mitigates Senescence and Inflammaging in Human Skin ModelsChristina Yan Ru Tan, Malgorzata Morenc, Melina Setiawan, et al.
The Lancet. Gastroenterology & Hepatology|July 26, 2018
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based seriesEnric Domingo, Carme Camps, Pamela J Kaisaki, et al.
Pageof 99